Literature DB >> 17030569

V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis.

Marcel Wüthrich1, Hanna I Filutowicz, Holly L Allen, George S Deepe, Bruce S Klein.   

Abstract

Immunization with a cell wall/membrane (CW/M) and yeast cytosol extract (YCE) crude antigen from Blastomyces dermatitidis confers T-cell-mediated resistance against lethal experimental infection in mice. We isolated and characterized T cells that recognize components of these protective antigens and mediate protection. CD4+ T-cell clones elicited with CW/M antigen adoptively transferred protective immunity when they expressed a V alpha2+ J alpha49+/V beta1+ J beta1.1+ heterodimeric T-cell receptor (TCR) and produced high levels of gamma interferon (IFN-gamma). In contrast, V beta8.1/8.2+ CD4+ T-cell clones that were reactive against CW/M and YCE antigens and produced little or no IFN-gamma either failed to mediate protection or exacerbated the infection depending on the level of interleukin-5 expression. Thus, the outgrowth of protective T-cell clones against immunodominant antigens of B. dermatitidis is biased by a combination of the TCR repertoire and Th1 cytokine production.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17030569      PMCID: PMC1828383          DOI: 10.1128/IAI.01148-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

Review 1.  Blastomycosis.

Authors:  G A Sarosi; S F Davies
Journal:  Am Rev Respir Dis       Date:  1979-10

2.  The protective immune response to heat shock protein 60 of Histoplasma capsulatum is mediated by a subset of V beta 8.1/8.2+ T cells.

Authors:  Mark Scheckelhoff; George S Deepe
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

3.  Requisite elements in vaccine immunity to Blastomyces dermatitidis: plasticity uncovers vaccine potential in immune-deficient hosts.

Authors:  Marcel Wüthrich; Hanna I Filutowicz; Tom Warner; Bruce S Klein
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

4.  Differential requirements of T cell subsets for CD40 costimulation in immunity to Blastomyces dermatitidis.

Authors:  Marcel Wüthrich; Phil L Fisette; Hanna I Filutowicz; Bruce S Klein
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

5.  Functional properties of the T cell receptor repertoire in responding to the protective domain of heat-shock protein 60 from Histoplasma capsulatum.

Authors:  George S Deepe; Reta S Gibbons
Journal:  J Infect Dis       Date:  2002-08-20       Impact factor: 5.226

6.  Mutation of the WI-1 gene yields an attenuated blastomyces dermatitidis strain that induces host resistance.

Authors:  M Wüthrich; H I Filutowicz; B S Klein
Journal:  J Clin Invest       Date:  2000-12       Impact factor: 14.808

Review 7.  Immunity to fungal infections.

Authors:  Luigina Romani
Journal:  Nat Rev Immunol       Date:  2004-01       Impact factor: 53.106

8.  Mouse model of pulmonary blastomycosis: utility, simplicity, and quantitative parameters.

Authors:  R P Harvey; E S Schmid; C C Carrington; D A Stevens
Journal:  Am Rev Respir Dis       Date:  1978-04

9.  The mouse (Mus musculus) T cell receptor alpha (TRA) and delta (TRD) variable genes.

Authors:  Nathalie Bosc; Marie-Paule Lefranc
Journal:  Dev Comp Immunol       Date:  2003 Jun-Jul       Impact factor: 3.636

10.  Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts.

Authors:  Marcel Wuthrich; Hanna I Filutowicz; Tom Warner; George S Deepe; Bruce S Klein
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  8 in total

1.  A TCR transgenic mouse reactive with multiple systemic dimorphic fungi.

Authors:  Marcel Wüthrich; Chiung Yu Hung; Ben H Gern; John C Pick-Jacobs; Kevin J Galles; Hanna I Filutowicz; Garry T Cole; Bruce S Klein
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 2.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

Review 3.  Adaptive immunity to fungi.

Authors:  Marcel Wüthrich; George S Deepe; Bruce Klein
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527

4.  Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes.

Authors:  Marcel Wüthrich; Karen Ersland; Thomas Sullivan; Kevin Galles; Bruce S Klein
Journal:  Immunity       Date:  2012-04-05       Impact factor: 31.745

5.  Calnexin induces expansion of antigen-specific CD4(+) T cells that confer immunity to fungal ascomycetes via conserved epitopes.

Authors:  Marcel Wüthrich; Tristan T Brandhorst; Thomas D Sullivan; Hanna Filutowicz; Alana Sterkel; Douglas Stewart; Mengyi Li; Tassanee Lerksuthirat; Vanessa LeBert; Zu Ting Shen; Gary Ostroff; George S Deepe; Chiung Yu Hung; Garry Cole; Jennifer A Walter; Marc K Jenkins; Bruce Klein
Journal:  Cell Host Microbe       Date:  2015-03-19       Impact factor: 31.316

6.  Vaccines for invasive fungal infections.

Authors:  Brad Spellberg
Journal:  F1000 Med Rep       Date:  2011-07-01

7.  Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.

Authors:  Marcel Wüthrich; Benjamin Gern; Chiung Yu Hung; Karen Ersland; Nicole Rocco; John Pick-Jacobs; Kevin Galles; Hanna Filutowicz; Thomas Warner; Michael Evans; Garry Cole; Bruce Klein
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 19.456

8.  Structure and function of a fungal adhesin that binds heparin and mimics thrombospondin-1 by blocking T cell activation and effector function.

Authors:  T Tristan Brandhorst; René Roy; Marcel Wüthrich; Som Nanjappa; Hanna Filutowicz; Kevin Galles; Marco Tonelli; Darrell R McCaslin; Kenneth Satyshur; Bruce Klein
Journal:  PLoS Pathog       Date:  2013-07-11       Impact factor: 6.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.